HeartBeam

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

HeartBeam reports Q1 loss, eyes FDA clearances for growth

HeartBeam's Q1 2024 performance showed financial challenges but promising technological advancements
The company's focus on FDA clearances and AI development positions it for growth
Opportunities in remote cardiac monitoring and AI-driven healthcare present avenues for expansion
Balancing financial stability with innovation will be key for HeartBeam's future success

HeartBeam advances AIMIGo technology despite financial challenges

HeartBeam is making progress towards FDA clearance for its innovative cardiac monitoring device, AIMIGo.
Despite financial challenges, the company's strong IP protection and AI capabilities position it well for future growth.
Opportunities lie in expanding technology applications, gaining regulatory approval, and leveraging AI for automated diagnostics.

HeartBeam reports Q3 loss, progresses FDA review, and strengthens leadership

HeartBeam's Q3 2024 financials show a net loss of $4.979 million, with a focus on managing cash burn and aligning capital raising with milestones.
The company's core technology and clinical evidence position it well for FDA clearances and commercial launch preparations.
New management appointments bring leadership strength to drive HeartBeam's growth and innovation in cardiac care.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Source: shutterstock.com/Anastasia Zagoruyko HeartBeam (NASDAQ: BEAT ) stock is rocketing higher on Thursday as investors react to news of a new heart monitor patent. This new patent covers a 12-lead electrocardiogram patch that's designed to monitor for acute coronary syndrome, as well as cardiac arrhythmia.

What Is Going on With HeartBeam (BEAT) Stock Today?

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

HeartBeam Granted Patent for 12-Lead Electrocardiogram (ECG) Patch Monitor Intended for Detection of Heart Attacks and Complex Cardiac Arrhythmias

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time

HeartBeam to Host Virtual Roadshow Webinar on Tuesday September 20, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product

HeartBeam Announces FDA Submission of HeartBeam AIMI™ Product

HeartBeam, Inc. (NASDAQ:BEAT ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Branislav Vajdic - Chief Executive Officer & Founder Jon Hunt - Chief Business Officer Rick Brounstein - Chief Financial Officer Conference Call Participants Bill Sutherland - The Benchmark Company Jason Kolbert - Dawson James Operator Greetings and welcome to the HeartBeam Second Quarter 2022 Financial Results Conference Call. At this time, all participants will be in a listen-only mode.

HeartBeam, Inc. (BEAT) CEO Branislav Vajdic on Q2 2022 Results - Earnings Call Transcript

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2022 Financial Results

HeartBeam Reports Second Quarter 2022 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Names Ken Persen as Chief Technology Officer

HeartBeam Names Ken Persen as Chief Technology Officer

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Wins CVI 2022 Innovation Summit Award

HeartBeam Wins CVI 2022 Innovation Summit Award

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time

HeartBeam to Host Second Quarter 2022 Results Conference Call on Thursday August 11, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Expands Patient Population for Emergency Department Software Technology Solution

HeartBeam Expands Patient Population for Emergency Department Software Technology Solution

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022

HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

HeartBeam to Participate in the H.C. Wainwright Global Investment Conference May 23-26, 2022

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports First Quarter 2022 Financial Results

HeartBeam Reports First Quarter 2022 Financial Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time

HeartBeam to Host First Quarter 2022 Results Conference Call on Thursday May 12, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Fourth Quarter and Full Year 2021 Financial Results

HeartBeam Reports Fourth Quarter and Full Year 2021 Financial Results

HeartBeam Inc (NASDAQ: BEAT) has signed a professional services agreement with Triple Ring Technologies Inc to assist in the design and development of its Telehealth complete solution 3D vector Electrocardiogram (ECG) collection device for remote heart attack or myocardial.

HeartBeam, Triple Ring To Co-Develop Telehealth Solution Device For Heart Attack Monitoring

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Partners with Triple Ring Technologies to Co-Develop Telehealth Solution Device

HeartBeam Partners with Triple Ring Technologies to Co-Develop Telehealth Solution Device

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Fourth Quarter and Full Year 2021 Results Conference Call on Thursday, March 24, 2022 at 4:30 p.m. Eastern Time

HeartBeam to Host Fourth Quarter and Full Year 2021 Results Conference Call on Thursday, March 24, 2022 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Partners with Phoebe Putney Health System for First Pilot Study of Emergency Department Myocardial Infarction Software

HeartBeam Partners with Phoebe Putney Health System for First Pilot Study of Emergency Department Myocardial Infarction Software

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Partners with LIVMOR for Cloud Based Remote Monitoring Portal

HeartBeam Partners with LIVMOR for Cloud Based Remote Monitoring Portal

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Establishes Scientific Advisory Board and Appoints C. Michael Gibson, MD as Chairman

HeartBeam Establishes Scientific Advisory Board and Appoints C. Michael Gibson, MD as Chairman

Bluejay Diagnostics

Blackboxstocks

Bridgeline Digital

China Liberal Education Holdings 

Data Storage Corp

G Medical Innovations Holdings Ltd

Lucid Diagnostics

NeuroBo Pharmaceuticals Inc

Nxt-ID

If you're willing to absorb massive risk for the chance of significant upside, these low-float penny stocks could fit the bill. The post 10 Low-Float Penny Stocks for Steel-Gutted Investors appeared first on InvestorPlace.

10 Low-Float Penny Stocks for Steel-Gutted Investors

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Participate in the H.C. Wainwright BIOCONNECT Conference

HeartBeam to Participate in the H.C. Wainwright BIOCONNECT Conference

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Appoints Alan Baumel as Chief Operating Officer

HeartBeam Appoints Alan Baumel as Chief Operating Officer

BioDelivery Sciences

OPKO Health

Check these penny stocks out for your watchlist right now The post Making a List of Penny Stocks to Buy? Check These 3 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

News for HeartBeam Stock (BEAT)